Table 2.
Laboratory findings of the second patient before treatment and four weeks after treatment
| Laboratory Parameter | Before treatment | After treatment | Normal Range |
|---|---|---|---|
| White Blood Cells | 960* | 6510 | 4-10 (*109/L) |
| Neutrophil count | 240* (25.1%) | 2930 (42%) | 2-7(*109/L) |
| Lymphocyte count | 510* (53.1%) | 2620 (40.2%) | 0.8-4(*109/L) |
| Monocyte count | 140 (20.8%) | 920 (14%) | 120-800(*109/L) |
| Hemoglobin | 7.8* | 9.7 | 11-13.5(g/dL) |
| Platelets | 13,000* | 240,000 | 150-450(*109/L) |
| ESR | 40 | 24 | 0-10(mm/hr) |
| CRP | 101 | 45 | <6(mg/dL) |
| AST | 89* | 51 | 10-31(IU/L) |
| ALT | 52* | 42 | 10-31(IU/L) |
| Triglyceride | 508* | 110 | <150(mg/dL) |
| LDH | 1200* | 270 | 105-333(IU/l) |
| Ferritin | 8490* | 182 | 30-220(ug/L) |
| Fibrinogen | 93* | 453 | 150-350(mg/dL) |
Asterisk points to the laboratory changes in favor of HLH
ESR Erythrocyte sedimentation rate test, CRP C-reactive protein, AST Aspartate aminotransferase, ALT Alanine aminotransferase, LDH Lactate dehydrogenase